Autres langues Scope Fluidics S.A.

Actions

SCP

PLSCPFL00018

Recherche biotechnologique et médicale

PEA

Marché Fermé - Warsaw S.E. 17:55:50 13/08/2026			Varia. 5j.	Varia. 1 janv.
136,60 ^PLN	-0,15 %		+0,74 %	+0,29 %

27/05	Scope Fluidics annonce l'obtention par Bacteromic d'un brevet américain pour une 'puce microfluidique'	RE
15/05	Scope Fluidics : perte nette de 13,5 millions de zlotys au premier trimestre	RE

Autres langues

27/05	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'
15/05	Scope Fluidics Q1 net loss at 13.5 million zlotys
15/05	Scope Fluidics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026
21/04	Scope Fluidics unit Bacteromic starts collaboration with US research center for FDA registration trials
25/03	Scope Fluidics FY net loss at 46.4 million zlotys
25/03	Scope Fluidics S.A. Reports Earnings Results for the Full Year Ended December 31, 2025
09/03	Scope Fluidics updates objectives for Bacteromic project for 2026-2027
20/02	Scope Fluidics obtains CE-IVDR certification for Bacteromic System
11/02	Scope Fluidics unit adopts plan for production readiness for Bacteromic system panels
21/01	Scope Fluidics unit signs framework distribution deal with SC Elta 90 Medical Research
08/01	Scope Fluidics signs distribution deal for Bacteromic system in Turkey
23/12	Scope Fluidics says unit Bacteromic ends cooperation with MicroLiquid
12/12	Scope Fluidics says unit receives conditional grant approval for Hybolic project
01/12	Scope Fluidics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
01/12	Scope Fluidics Q3 net loss at 11.4 million zlotys
03/11	Scope Fluidics says shareholder sells stake in company
29/10/25	Scope Fluidics says shareholders complete ABB process for 16% of stake
27/10/25	Scope Fluidics starts ABB process
27/10/25	Scope Fluidics to raise share capital via issue of up to 0.4 million new shares
26/09/25	Scope Fluidics extends collaboration for FDA certification
19/09/25	Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
19/09/25	Scope Fluidics Q2 net loss at 8.6 mln zlotys
16/09/25	Scope Fluidics approves timeline change for Hybolic project goal
15/09/25	Scope Fluidics board okays EIB financing pursuit for Bacteromic
06/08/25	Scope Fluidics informs about achieving first goal in Edocera project